You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oprozomib

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • oprozomib
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Advanced Non-CNS (CNS) Malignancies Trial in United States (Oprozomib, Midazolam)

Terminated
  • Advanced Non-Central Nervous System (CNS) Malignancies
  • Aurora, Colorado
  • +6 more
Feb 18, 2021

Multiple Myeloma Trial in United States (Oprozomib, Lenalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Oprozomib
  • +3 more
  • Huntsville, Alabama
  • +13 more
Mar 2, 2021

Multiple Myeloma Trial in United States (Oprozomib, Pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Oprozomib
  • +2 more
  • Encinitas, California
  • +16 more
Mar 31, 2021

Multiple Myeloma Trial in France, United States (Oprozomib, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Los Angeles, California
  • +12 more
Jun 22, 2020

Solid Tumors Trial in Scottsdale, Nashville, San Antonio (Oprozomib)

Completed
  • Solid Tumors
  • Oprozomib
  • Scottsdale, Arizona
  • +2 more
Apr 28, 2017

Advanced Hepatocellular Carcinoma Trial in United States (Oprozomib, Sorafenib)

Withdrawn
  • Advanced Hepatocellular Carcinoma
  • Burlington, California
  • +5 more
Apr 28, 2017

Multiple Myeloma Trial in Greece, Italy, Netherlands (Oprozomib, Melphalan, Prednisone)

Completed
  • Multiple Myeloma
  • Oprozomib
  • +2 more
  • Athens, Attica, Greece
  • +7 more
Apr 28, 2017